Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
---|
09/22/2009 | US7592360 3-fluoro-piperidines as NMDA/NR2B antagonists |
09/22/2009 | US7592347 Piperazine derivates and their use for the treatment of neurological and psychiatric diseases |
09/22/2009 | US7592346 e.g. 3-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-1,3-oxazolidin-2-one; serotonin receptor antagonist and inverse agonists, agonists or partial agonists, serotonin reuptake inhibitor; antidepressant, anxiolytic agent |
09/22/2009 | US7592340 Quinoxalines useful as inhibitors of protein kinases |
09/22/2009 | US7592339 Substituted oxazolidinones and their use in the field of blood coagulation |
09/22/2009 | US7592337 Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
09/22/2009 | CA2454584C Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising ep4 agonist as active ingredient |
09/22/2009 | CA2419588C Piperidine derivatives for use 2,3-oxidosqualene-lanosterol cyclase inhibitors |
09/22/2009 | CA2396720C Thiazolyl amide derivatives |
09/22/2009 | CA2209640C Cycloalkano-pyridines |
09/17/2009 | WO2009114744A1 Therapeutic compounds |
09/17/2009 | WO2009114677A1 Pyridazine derivatives as factor xia inhibitors |
09/17/2009 | WO2009114566A1 Novel compounds as cannabinoid receptor ligands |
09/17/2009 | WO2009114552A1 Heteroaryl compounds, compositions, and methods of use in cancer treatment |
09/17/2009 | WO2009113637A1 Novel thiazole derivative, matrix having thiazole derivative immobilized thereon, method for production of the thiazole derivative, and method for production of the matrix |
09/17/2009 | WO2009113600A1 Pyridylaminoacetic acid compound |
09/17/2009 | WO2009113569A1 Medicinal composition containing benzo[a]phenoxanthin compound as the active ingredient for preventing or treating protozoal disease |
09/17/2009 | WO2009112845A1 Amido-thiophene compounds and their use |
09/17/2009 | WO2009112533A1 Substituted triazinylmethyl sulfonamides |
09/17/2009 | WO2009112523A1 Substituted pyraz inylmethyl sulfonamides for use as. fungicides |
09/17/2009 | WO2009112490A1 Sulfonamides as zap-70 inhibitors |
09/17/2009 | WO2009112155A1 Heteroaryl-substituted dicyanopyridines and use thereof for treatment of cardiovascular diseases |
09/17/2009 | WO2009112077A1 Process for the preparation of epothilone precursor compounds |
09/17/2009 | WO2008075380A3 Process for the preparation of thiazolidine derivatives |
09/17/2009 | WO2007129195A3 4-pyrimidine-5-amino-pyrazole compounds |
09/17/2009 | US20090234128 Process for the Preparation of Intermediates of Rosiglitazone, Rosiglitazone and New Polymorphic Forms Thereof |
09/17/2009 | US20090233974 Substituted gamma lactams as therapeutic agents |
09/17/2009 | US20090233971 GSK-3 Inhibitors |
09/17/2009 | US20090233938 Thiazole derivatives as a2b antagonists |
09/17/2009 | US20090233931 Therapeutic compounds |
09/17/2009 | US20090233923 Pyrido-pyrimidine derivatives, preparation thereof, and therapeutic use thereof |
09/17/2009 | US20090233920 Organic compounds |
09/17/2009 | US20090233919 Thiazolopyridinone derivates as mch receptor antagonists |
09/17/2009 | US20090233901 Vla-4 inhibitory drug |
09/17/2009 | US20090233247 Infrared dye for silver halide-based photographic elements |
09/17/2009 | US20090232328 Digital sound processing system for a vehicle |
09/17/2009 | US20090229670 Organic photoelectric conversion material and photoelectric conversion element using the same |
09/17/2009 | DE102008013587A1 Heteroaryl-substituierte Dicyanopyridine und ihre Verwendung Heteroaryl substituted dicyanopyridines and their use |
09/17/2009 | CA2718393A1 Pyridylaminoacetic acid compound |
09/17/2009 | CA2717529A1 Sulfonamides as zap-70 inhibitors |
09/17/2009 | CA2716857A1 Novel compounds as cannabinoid receptor ligands |
09/17/2009 | CA2716679A1 Amido-thiophene compounds and their use |
09/17/2009 | CA2713367A1 Derivatives of tetrahydroquinoxaline urea, preparation thereof and therapeutic application thereof |
09/16/2009 | EP2100891A1 Inhibitors of tyrosine kinases |
09/16/2009 | EP2099794A2 Thiazolyl compounds useful as kinase inhibitors |
09/16/2009 | EP2099793A1 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
09/16/2009 | EP2099789A1 Inhibitors of hiv replication |
09/16/2009 | EP2099788A1 Cyclically substituted 3,5-dicyano-2-thiopyridines and use thereof |
09/16/2009 | EP2099781A1 Substituted 4-amino-3,5-dicyano-2-thiopyridines and use thereof |
09/16/2009 | EP2099778A2 Amido anti-viral compounds |
09/16/2009 | EP2099774A1 Inhibitors of kinase activity |
09/16/2009 | EP2099761A2 Antibacterial quinoline derivatives |
09/16/2009 | EP2099759A1 Antibacterial quinoline derivatives |
09/16/2009 | EP2099758A1 Antibacterial quinoline derivatives |
09/16/2009 | EP2099757A2 Sulfoximines as kinase inhibitors |
09/16/2009 | EP2099753A2 Heteroarylacrylamides and their use as pharmaceuticals |
09/16/2009 | EP1737450B1 Aqueous composition comprising a thiazole derivative |
09/16/2009 | EP1564210B1 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors |
09/16/2009 | EP1487807B1 Cyano-pyrrolidines as DPP-IV inhibitors |
09/16/2009 | EP1283834B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
09/16/2009 | CN101531683A Bipyridine ruthenium/osmium ECL marker with phenothiazine power supplying groups in molecules |
09/16/2009 | CN101531657A Dimethyldiguanide of the thiazolidinedione pharmaceutical, preparation method and use thereof |
09/16/2009 | CN100540552C 3-Cyanoquinoline derivative, preparation method and medical use thereof |
09/16/2009 | CN100540551C Quinoline derivative, preparation method and medical use thereof |
09/16/2009 | CN100540538C Large conductance calcium-activated k channel opener |
09/16/2009 | CN100540537C Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors |
09/16/2009 | CN100540001C Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative |
09/15/2009 | US7589212 {4-[2-(5-methyl-[1,3,4]thiadiazol-2-ylamino)-2-(4-phenylthiazol-2-yl)-ethyl]phenyl}sulfamic acid; anticarcinogenic, antitumor, antidiabrtic agent; angiogenesis inhibitor; sarcoid, syphilis, Paget's disease, vein occlusion, artery occlusion, carotid obstructive disease, chronic uveitis/vitritis |
09/15/2009 | US7589200 5-Fluoro-4N-phenyl-4-pyrimidineamine compounds |
09/15/2009 | US7589116 Biaryl substituted pyrazoles as sodium channel blockers |
09/15/2009 | US7589113 Substituted oxadiazole compounds and their use as opioid receptor ligands |
09/15/2009 | US7589112 Methylene urea derivatives |
09/15/2009 | US7589094 N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
09/15/2009 | CA2522323C 3-azabicyclo[3.2.1]octane derivatives as opioid receptor ligands |
09/15/2009 | CA2409819C Triazole derivatives |
09/15/2009 | CA2374902C Aminoalkyl substituted benzopyran derivatives for treating impaired fundic relaxation |
09/15/2009 | CA2323111C New substituted indolinones, the preparation thereof and their use as pharmaceutical compositions |
09/11/2009 | WO2009111442A1 AMINO-QUINOXALINE AND AMINO-QUINOLINE COMPOUNDS FOR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS |
09/11/2009 | WO2009110510A1 Alkylaminopyridine derivative |
09/11/2009 | WO2009109999A1 Novel protein tyrosine phosphatase - ib inhibitors |
09/11/2009 | WO2009109907A1 Novel pyrimidine-pyridine derivatives |
09/11/2009 | WO2009109608A1 Novel compounds |
09/11/2009 | WO2009109576A1 Pim kinase inhibitors and methods of their use |
09/11/2009 | WO2009109270A1 5-oxo-2, 3,4,5-tetrahydro-benzo[b]oxepine-4-carboxylic acid amides and 2,3-dihydro-benzo[b]oxepine-4-carboxylic acid amides for treatment and prevention of diabetes typ 1 and 2 |
09/11/2009 | WO2009071650A3 Amide compounds as boosters of antivirals |
09/11/2009 | CA2717388A1 Pim kinase inhibitors and methods of their use |
09/11/2009 | CA2717287A1 5-oxo-2,3,4,5-tetrahydro-benzo[b]oxepine-4-carboxylic acid amides and 2,3-dihydro-benzo[b]oxepine-4-carboxylic acid amides for treatment and prevention of diabetes type 1 and 2 |
09/11/2009 | CA2717171A1 Amino-quinoxaline and amino-quinoline compounds for use as adenosine a2a receptor antagonists |
09/11/2009 | CA2716136A1 Hexahydrocyclopentyl[f]indazole sulfonamides and derivatives thereof as selective glucocorticoid receptor modulators |
09/11/2009 | CA2714617A1 Alkylaminopyridine derivative |
09/11/2009 | CA2714614A1 Novel pyrimidine-pyridine derivatives |
09/11/2009 | CA2711247A1 2-aminoquinolines |
09/11/2009 | CA2625306A1 Electron acceptors-cored regioregular oligothiophenes as building blocks for soluble low band-gap conjugated polymers |
09/10/2009 | US20090227797 Modulators of atp-binding cassette transporters |
09/10/2009 | US20090227789 Ethylenediamine derivatives |
09/10/2009 | US20090227788 Process for preparing benzothiazepines from gamma-aminoalkylbenzenes |
09/10/2009 | US20090227638 Novel Pharmaceutical Compounds |
09/10/2009 | US20090227635 Therapeutic compounds |
09/10/2009 | US20090227600 4-(pyrazine-2-yl) -pyrrolidine -2-carboxylic acid compounds and derivatives thereof as hepatitis c virus inhibitors |
09/10/2009 | US20090227596 Heteroaryl nitrile derivatives |